Cargando…

Endocrine Toxicities of Antineoplastic Therapy

Detalles Bibliográficos
Autores principales:	Puliani, Giulia, Appetecchia, Marialuisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830439/ https://www.ncbi.nlm.nih.gov/pubmed/33466843 http://dx.doi.org/10.3390/cancers13020294

Ejemplares similares

Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic
por: Barnabei, Agnese, et al.
Publicado: (2022)

Metabolic and Endocrine Toxicities of Mitotane: A Systematic Review
por: Bianchini, Marta, et al.
Publicado: (2021)

New Perspectives on Diagnostics, Prognosis, and Therapy in Aggressive Endocrine Tumours
por: Appetecchia, Marialuisa, et al.
Publicado: (2012)

Endocrine Disrupting Chemicals: Effects on Endocrine Glands
por: Lauretta, Rosa, et al.
Publicado: (2019)

New Insights in PRRT: Lessons From 2021
por: Puliani, Giulia, et al.
Publicado: (2022)

A Rare Case of Pituitary Melanoma Metastasis: A Dramatic and Prolonged Response to Dabrafenib-Trametinib Therapy
por: Mormando, Marilda, et al.
Publicado: (2020)

Antineoplastics: Various toxicities: case report
Publicado: (2020)

Antineoplastics: Various toxicities: case report
Publicado: (2020)

Antineoplastics: Various toxicities: case report
Publicado: (2022)

Antineoplastics: Various toxicities: case report
Publicado: (2022)

392 Lung Toxicity Induced by Novel Antineoplastic Therapies in Cancer Patients
por: Syrigos, Kostas N., et al.
Publicado: (2012)

Design and Synthesis of Organic Molecules as Antineoplastic Agents
por: Boga, Carla, et al.
Publicado: (2020)

Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study
por: Mormando, Marilda, et al.
Publicado: (2023)

Antineoplastics: Multisystem toxicities: 6 case reports
Publicado: (2020)

Antineoplastics: Various toxicities: 3 case reports
Publicado: (2019)

Antineoplastics: Various toxicities: 3 case reports
Publicado: (2020)

Antineoplastics: Various toxicities: 3 case reports
Publicado: (2022)

Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review
por: Barnabei, Agnese, et al.
Publicado: (2020)

Antineoplastics: Various toxicities and lack of efficacy: case report
Publicado: (2021)

Antineoplastics/hydrocortisone: Various toxicities: 15 case reports
Publicado: (2021)

Antineoplastics: Various toxicities and treatment failure: case report
Publicado: (2022)

Pulmonary Effects of Antineoplastic Therapy
por: Dhakal, Sughosh, et al.
Publicado: (2015)

Ocular complications of antineoplastic therapies
por: Bader, Abbas, et al.
Publicado: (2023)

Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
por: Appetecchia, Marialuisa, et al.
Publicado: (2010)

Antineoplastics: Chemotherapy-induced pulmonary toxicity: 2 case reports
Publicado: (2022)

Cell death regulation in myocardial toxicity induced by antineoplastic drugs
por: Yu, Xue, et al.
Publicado: (2023)

Editor’s choice 2019: Oxidative stress and antineoplastic agents
por: Ghallab, Ahmed
Publicado: (2020)

Editorial for the Special Issue “New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies”
por: Martínez-Campa, Carlos, et al.
Publicado: (2020)

Gender in Endocrine Diseases: Role of Sex Gonadal Hormones
por: Lauretta, R., et al.
Publicado: (2018)

Antineoplastics/diphenoxylate/loperamide: Various toxicities and lack of efficacy : case report
Publicado: (2021)

Endocrine therapy: defining the path of least resistance
por: Stone, Andrew, et al.
Publicado: (2014)

The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation
por: Sobrero, Alberto
Publicado: (2017)

The Impact of Endocrine Disruptors on Endocrine Targets
por: Gregoraszczuk, Ewa L., et al.
Publicado: (2013)

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
por: van Dorst, Daan C.H., et al.
Publicado: (2021)

Melanoma and Sarcoidosis in Patients Receiving or Not Antineoplastic Therapy
por: Gouveris, Panagiotis, et al.
Publicado: (2021)

Dental anomalies in children submitted to antineoplastic therapy
por: Carrillo, Camila Merida, et al.
Publicado: (2014)

Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy
por: Chis, Adriana Aurelia, et al.
Publicado: (2022)

Doing the Dirty Work: Who Handles Antineoplastic Drug Contaminated Excreta and do They Do It Safely?
por: Walton, AnnMarie Lee
Publicado: (2017)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

An unmet need: tailoring extended adjuvant endocrine therapy
por: Bianchini, G, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hvsltfldqum33kfk0aee6mkjda